Cuorips

IPO

Cuorips is a biotech company in Osaka, Japan, founded in 2017. It has raised $19.3M across 1 round, most recently a $19.3M Venture Round in December 2020.

Cuorips Inc. | Pioneering the Future of Cell Therapeutics

Headquarters
Osaka
Employees
51–200
Founded
2017
Business Model
B2B
Total Funding
$19.3M
Last Round
$19.3M Venture RoundDec 2020
Rounds
1
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 3 investors for this company. The full record is or through the API.

About

Cuorips Inc. is a Japan-based cell-therapeutics company whose name combines the Italian word for heart with 'iPS' (induced pluripotent stem) cells. Founded March 21, 2017 and headquartered in Osaka, Cuorips develops iPSC-derived cell therapies including RiHEART, a pioneering cardiac patch, alongside catheter-delivered therapies and small-molecule programs, using its VMaCS platform to mass-manufacture and deliver cell therapies globally.

Summary

It lists 51–200 employees. It has raised $19.3M in total across 1 round, most recently a $19.3M Venture Round in Dec 2020. Investors include JIC Venture Growth Investments, Kyoto University Innovation Capital and Jafco Ventures.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Data from Indexed.vcUpdated
IPOJun 2023

Sign up to see all 2 events

Funding: Venture Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Cuorips on Indexed.vc
<a href="https://indexed.vc/companies/cuorips"><img src="https://indexed.vc/api/badge/company/cuorips" alt="Cuorips on Indexed.vc" width="260" height="76" /></a>